Physostigmine in Tourette syndrome: evidence for cholinergic underactivity.
D000293:Adolescent; D000328:Adult; D002648:Child; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D010830:Physostigmine / Q000627:therapeutic use*; D011950:Receptors, Cholinergic / Q000187:drug effects* / Q000378:metabolism; D005879:Tourette Syndrome / Q000188:drug therapy* / Q000378:metabolism
D011950:Receptors, Cholinergic; D010830:Physostigmine; D004298:Dopamine